Author

Ana Márquez‐López

Universidad de CantabriaORCID 0000-0003-4220-6501Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

Mónica L. FanárragaiD· 2 shared Andrés Ramos‐ValleiD· 1 shared Anna Maria AviñóiD· 1 shared Arnau DomíngueziD· 1 shared Carme FàbregaiD· 1 shared Lorena García‐HeviaiD· 1 shared Natalia NavarroiD· 1 shared Ramón EritjaiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Mónica L. FanárragaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringSmallPeer-reviewedApr 21, 2025

Targeted Tumor Microenvironment Delivery of Floxuridine Prodrug via Soluble Silica Nanoparticles in Malignant Melanoma as a Model for Aggressive Cancer Treatment

Andrés Ramos‐Valle, Arnau Domínguez, Natalia Navarro…·Mónica L. Fanárraga

This paper develops a targeted drug delivery system using silica nanoparticles to deliver a floxuridine prodrug, achieving significant tumor reduction in melanoma models.

5 citations

mouseexperimental assay

𝕏 PostBluesky

Molecular BiologybioRxivPreprintDec 5, 2024

Engineering an Anthrax Toxin inspired protein-ligand for Nanoparticle-Mediated Treatment of Malignant Melanoma

Ana Márquez‐López, Mónica L. Fanárraga

This paper develops PA17, a toxin-derived ligand targeting TEM8 in melanoma, which enhances nanoparticle-mediated drug delivery and reduces tumor mass effectively.

2 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky